HCT
vs
S
S&P/ASX 300
HCT
Over the past 12 months, HCT has significantly outperformed S&P/ASX 300, delivering a return of +133% compared to the S&P/ASX 300's +10% growth.
Stocks Performance
HCT vs S&P/ASX 300
Performance Gap
HCT vs S&P/ASX 300
Performance By Year
HCT vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Holista CollTech Ltd
Glance View
Holista CollTech Ltd. engages in the research, development, manufacture, and marketing of natural ingredients and wellness products. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2004-02-26. The firm is focused on researching, developing, manufacturing, and marketing health-style products. The firm's segments include Supplements, Ovine collagen, Food ingredients, and Infection control. The Supplements segment is engaged in the manufacture and wholesale distribution of dietary supplements. Ovine collagen is engaged in the manufacture and distribution of cosmetic-grade collagen. The Food ingredients segment is engaged in the manufacture and wholesale distribution of healthy food ingredients. Infection control segment is engaged in the infection control solutions. Its Path-Away technology is developed from bioflavonoids, which kill approximately 170 viruses, bacteria and fungi-naturally and without side effects. The firm's products include M3 System, FogClean, OVICOLL 98, OVICOLL 95, OVINEX and GILite.
